SetPoint Medical Corporation
Latest round
- Series D
Last raised
- Mar 2025
Total raised
- $321M
Investors
- 25
About SetPoint Medical Corporation
SetPoint Medical Corporation, based in the US, develops innovative treatment solutions utilizing proprietary Neuroimmune Modulation technology aimed at regulating inflammation and restoring immunologic balance for chronic autoimmune diseases. SetPoint Medical Corporation specializes in advanced treatment solutions through its investigational medical device platform.00 mn. The CEO is Murthy Simhambhatla, who leads the company in its clinical research efforts and strategic partnerships.SetPoint Medical focuses on innovating treatment solutions through its proprietary platform, Neuroimmune Modulation, which employs targeted electrical stimulation to activate the body's immunomodulatory pathways. This technology aims to regulate inflammation and restore immunologic balance, primarily addressing chronic autoimmune diseases. The company’s core product offering is an investigational medical device intended for clinical use, aiming to enhance patient outcomes by providing a novel therapeutic approach. The technology targets patients suffering from chronic autoimmune conditions, particularly in the United States and global markets involved in clinical trials, and is supported by extensive clinical research to refine and expand its customer base among healthcare providers. SetPoint Medical generates revenue through its investigational medical device platform, focusing on clinical trials and partnerships with healthcare institutions. Collaborations with medical facilities and research organizations are integral for evaluating the efficacy of its Neuroimmune Modulation technology. While specific pricing details for its offerings have not been disclosed, revenue is primarily derived from partnerships, research grants, and potential future sales to healthcare providers following regulatory approval. The financial framework will evolve as the company progresses through clinical research and regulatory processes. The company plans to enhance its product offerings and expand its market reach, targeting new geographic regions for its investigational devices. SetPoint aims to solidify its presence in both existing and new markets as it advances its clinical trials and navigates regulatory pathways.
Who invested in SetPoint Medical Corporation
25 investors across 9 rounds
See all investors in SetPoint Medical Corporation
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
Mar 27, 2025
Amount
$115M
Investors
Series C
Jan 18, 2023
Amount
$55M
Investors
Series B
Jan 27, 2021
Amount
$12M
Investors
Series B
Oct 30, 2020
Amount
$52M
Investors
Series D
Aug 28, 2017
Amount
$30M
Investors
Series C
Aug 21, 2015
Amount
$15M
Investors
Series C
Aug 8, 2013
Amount
$31M
Investors
Series B
Oct 13, 2010
Amount
$5M
Investors
Series A
May 17, 2007
Amount
$6M
Investors
Questions about SetPoint Medical Corporation
Who invested in SetPoint Medical Corporation?
SetPoint Medical Corporation has 25 investors on record across 9 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SetPoint Medical Corporation raised?
SetPoint Medical Corporation has raised 9 venture rounds. Sign up free to see how much each round raised and the total.
When did SetPoint Medical Corporation last raise money?
SetPoint Medical Corporation's most recent round on record is a Series D, in Mar 2025.
What does SetPoint Medical Corporation do?
SetPoint Medical Corporation, based in the US, develops innovative treatment solutions utilizing proprietary Neuroimmune Modulation technology aimed at regulating inflammation and restoring immunologic balance for chronic autoimmune diseases.
Where is SetPoint Medical Corporation headquartered?
SetPoint Medical Corporation is headquartered in Valencia, US.
Which VCs invest in companies like SetPoint Medical Corporation?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at SetPoint Medical Corporation's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like SetPoint Medical Corporation? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.